|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| A61K 39/395 | (2006.01) |
| (11) | Number of the document | 4209510 |
| (13) | Kind of document | T |
| (96) | European patent application number | 22215991.5 |
| Date of filing the European patent application | 2009-12-08 | |
| (97) | Date of publication of the European application | 2023-07-12 |
| (45) | Date of publication and mention of the grant of the patent | 2024-01-31 |
| (46) | Date of publication of the claims translation | 2024-03-12 |
| (30) | Number | Date | Country code |
| 121092 P | 2008-12-09 | US |
| (72) |
IRVING, Bryan , US
CHEUNG, Jeanne , US
CHIU, Henry , US
LEHAR, Sophie M. , US
MAECKER, Heather , US
MARIATHASAN, Sanjeev , US
WU, Yan , US
|
| (73) |
F. Hoffmann-La Roche AG ,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Anti-PD-L1 antikūnai ir jų panaudojimas T ląstelių funkcijos pagerinimui |
| ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION |
| Payment date | Validity (years) | Amount | |
| 2024-11-21 | 16 | 347.00 EUR |
| 2025-12-08 |